The emerging role for biomodulation of antineoplastic agents.
Schmoll
H J
HJ
Department of Internal Medicine, Hannover University Medical School, Germany.
Hiddemann
W
W
Rustum
Y
Y
Köhne-Wömpner
C H
CH
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D016898:Interferon-alpha; D001224:Aspartic Acid; D004176:Dipyridamole; C013195:sparfosic acid; D010746:Phosphonoacetic Acid; D005472:Fluorouracil